其中肝细胞性肝癌77例(84.6%),胆管癌9例(9.9%),混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
其中肝细胞性肝癌77例(84.6%),胆管癌9例(9.9%),混合细胞性肝癌2例(2.2%)和肝母细胞瘤3例(3.3%)。
Among all the cases studies, 77 (84.6%) were of hepatocellular carcinoma, 9 (9.9%) of cholangiocarcinoma, 2 (2.2%) of mixed cell carcinoma, and 3 (3.3%;) of hepatoblastoma.
应用推荐